Literature DB >> 11178911

Solution structure of Grb2 reveals extensive flexibility necessary for target recognition.

S Yuzawa1, M Yokochi, H Hatanaka, K Ogura, M Kataoka, K Miura , V Mandiyan, J Schlessinger, F Inagaki.   

Abstract

Grb2 is an adaptor protein composed of a single SH2 domain flanked by two SH3 domains. Grb2 functions as an important evolutionary conserved link between a variety of cell membrane receptors and the Ras/MAP kinase-signaling cascade. Here, we describe the solution structure of Grb2 as revealed by NMR and small angle X-ray scattering measurements. We demonstrate that Grb2 is a flexible protein in which the C-terminal SH3 domain is connected to the SH2 domain via a flexible linker. This is in contrast to the previously described Grb2 crystal structure, which showed a compact structure with intramolecular contact between two SH3 domains. Binding experiments on Grb2 and peptides containing two different proline-rich sequences indicate that Grb2 adapts the relative position and orientation of the two SH3 domains to bind bivalently to the target peptide sequences.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11178911     DOI: 10.1006/jmbi.2000.4396

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  17 in total

1.  Backbone assignments of Grb2 complexed with ligand peptides for SH3 and SH2 domains.

Authors:  Satoru Yuzawa; Kenji Ogura; Hideki Hatanaka; Kin-ichiro Miura; Fuyuhiko Inagaki
Journal:  J Biomol NMR       Date:  2003-10       Impact factor: 2.835

2.  Application of ring-closing metathesis to Grb2 SH3 domain-binding peptides.

Authors:  Fa Liu; Alessio Giubellino; Philip C Simister; Wenjian Qian; Michael C Giano; Stephan M Feller; Donald P Bottaro; Terrence R Burke
Journal:  Biopolymers       Date:  2011       Impact factor: 2.505

3.  Quantitative relation between intermolecular and intramolecular binding of pro-rich peptides to SH3 domains.

Authors:  Huan-Xiang Zhou
Journal:  Biophys J       Date:  2006-08-04       Impact factor: 4.033

4.  Aggregation of membrane proteins by cytosolic cross-linkers: theory and simulation of the LAT-Grb2-SOS1 system.

Authors:  Ambarish Nag; Michael I Monine; James R Faeder; Byron Goldstein
Journal:  Biophys J       Date:  2009-04-08       Impact factor: 4.033

5.  Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.

Authors:  Logan W Donaldson; Gerald Gish; Tony Pawson; Lewis E Kay; Julie D Forman-Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-16       Impact factor: 11.205

6.  Regions outside of conserved PxxPxR motifs drive the high affinity interaction of GRB2 with SH3 domain ligands.

Authors:  Rebekah R Bartelt; Jonathan Light; Aldo Vacaflores; Alayna Butcher; Madhana Pandian; Piers Nash; Jon C D Houtman
Journal:  Biochim Biophys Acta       Date:  2015-06-12

7.  Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-mediated signaling and anaplastic large cell lymphoma growth.

Authors:  Ludovica Riera; Elena Lasorsa; Chiara Ambrogio; Nadia Surrenti; Claudia Voena; Roberto Chiarle
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

8.  Structure and flexibility within proteins as identified through small angle X-ray scattering.

Authors:  Martin Pelikan; Greg L Hura; Michal Hammel
Journal:  Gen Physiol Biophys       Date:  2009-06       Impact factor: 1.512

Review 9.  The adaptor protein LAT serves as an integration node for signaling pathways that drive T cell activation.

Authors:  Rebekah R Bartelt; Jon C D Houtman
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2012-11-13

10.  Functional anthology of intrinsic disorder. 2. Cellular components, domains, technical terms, developmental processes, and coding sequence diversities correlated with long disordered regions.

Authors:  Slobodan Vucetic; Hongbo Xie; Lilia M Iakoucheva; Christopher J Oldfield; A Keith Dunker; Zoran Obradovic; Vladimir N Uversky
Journal:  J Proteome Res       Date:  2007-03-29       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.